Wells Fargo slashes price target on NOV Inc. [NOV] – find out why.

NOV Inc. [NYSE: NOV] loss -0.65% on the last trading session, reaching $22.98 price per share at the time. The company report on November 17, 2022 that NOV Declares Regular Quarterly Dividend.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


NOV Inc. (NYSE: NOV) today announced that its Board of Directors declared the regular quarterly cash dividend of $0.05 per share of common stock, payable on December 23, 2022 to each stockholder of record on December 9, 2022.

If compared to the average trading volume of 3.47M shares, NOV reached a trading volume of 2843551 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here is what top equities market gurus are saying about NOV Inc. [NOV]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for NOV shares is $24.53 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on NOV stock is a recommendation set at 2.40. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Wells Fargo have made an estimate for NOV Inc. shares, keeping their opinion on the stock as Equal Weight, with their previous recommendation back on November 07, 2022. The new note on the price target was released on October 12, 2022, representing the official price target for NOV Inc. stock. Previously, the target price had yet another raise to $19, while BofA Securities analysts kept a Buy rating on NOV stock.

The Average True Range (ATR) for NOV Inc. is set at 0.87, with the Price to Sales ratio for NOV stock in the period of the last 12 months amounting to 1.31. The Price to Book ratio for the last quarter was 1.85, with the Price to Cash per share for the same quarter was set at 2.62.

Trading performance analysis for NOV stock

NOV Inc. [NOV] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 0.39. With this latest performance, NOV shares gained by 17.36% in over the last four-week period, additionally plugging by 28.24% over the last 6 months – not to mention a rise of 79.25% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for NOV stock in for the last two-week period is set at 58.78, with the RSI for the last a single of trading hit 55.12, and the three-weeks RSI is set at 59.87 for NOV Inc. [NOV]. The present Moving Average for the last 50 days of trading for this stock 19.51, while it was recorded at 23.31 for the last single week of trading, and 18.45 for the last 200 days.

NOV Inc. [NOV]: A deeper dive into fundamental analysis

NOV Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.50 and a Current Ratio set at 2.30.

NOV Inc. [NOV]: An earnings per share (EPS) analysis

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for NOV. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for NOV Inc. go to 41.00%.

An analysis of insider ownership at NOV Inc. [NOV]

There are presently around $8,568 million, or 97.80% of NOV stock, in the hands of institutional investors. The top three institutional holders of NOV stocks are: VANGUARD GROUP INC with ownership of 38,925,240, which is approximately 0.905% of the company’s market cap and around 0.20% of the total institutional ownership; BLACKROCK INC., holding 36,290,714 shares of the stock with an approximate value of $833.96 million in NOV stocks shares; and FIRST EAGLE INVESTMENT MANAGEMENT, LLC, currently with $829.58 million in NOV stock with ownership of nearly 6.369% of the company’s market capitalization.

154 institutional holders increased their position in NOV Inc. [NYSE:NOV] by around 20,142,325 shares. Additionally, 166 investors decreased positions by around 32,668,888 shares, while 71 investors held positions by with 320,051,838 shares. The mentioned changes placed institutional holdings at 372,863,051 shares, according to the latest SEC report filing. NOV stock had 40 new institutional investments in for a total of 2,142,660 shares, while 47 institutional investors sold positions of 17,853,552 shares during the same period.


Please enter your comment!
Please enter your name here